Cancer Trials Database Comment Window Gets 30-Day Boost
Published Date: 3/10/2026
Notice
Summary
The National Cancer Institute is asking for 30 more days of public comments on their Clinical Trials Reporting Program (CTRP) database, which helps track cancer research studies. This correction fixes a previous notice and explains that no comments were received during the first 60 days. The program saves time by reducing duplicate reports, and there’s no cost except the time spent by researchers updating the database.
Analyzed Economic Effects
3 provisions identified: 1 benefits, 2 costs, 0 mixed.
Annual Time Burden on Researchers
Clinical research administrators and other respondents are estimated to spend a total of 18,000 hours per year on the CTRP database. The notice lists 9,000 respondents, 24,000 annual responses, and 18,000 estimated annualized burden hours.
Per-Report Time and Frequency Requirements
The CTRP requires initial trial registration that takes 1 hour, trial registration updates that take 1 hour, trial registration amendments that take 1 hour, and accrual updates that take 30 minutes each. The notice states there are three amendments and four accrual updates per trial each year.
No Monetary Costs; Fewer Duplicate Reports
The notice says there are no costs to respondents other than their time and that the CTRP consolidates reporting to reduce redundant submissions. OMB approval is requested for three years under control number 0925-0600.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-16683, Proposed Collection; 60-Day Comment Request; Data Use Certification for the NIH National Institute on Drug Abuse Data Share Site
The purpose of this notice is to inform the public of the information collection requirement for the NIDA Data Share, the data use terms and conditions, and to request a progress report statement at the time of renewal. In compliance with the requirement of the Paperwork Reduction Act of 1995 to provide opportunity for public comment on proposed data collection projects, the National Institute on Drug Abuse (NIDA) will publish periodic summaries of proposed projects to be submitted to the Office of Management and Budget (OMB) for review and approval.
2026-16544, Government-Owned Inventions; Availability for Licensing
The inventions listed below are owned by an agency of the U.S. Government and are available for licensing to achieve expeditious commercialization of results of federally-funded research for the benefit of the public health.
2026-16440, NIH Owned Invention Available for License: Soluble Tissue Factor, a Novel Target, and Antibodies, for Diagnosis, Prevention and Treatment of Thrombosis and Related Conditions
Scientists at the National Cancer Institute (NCI) have discovered a novel therapeutic, diagnostic and prognostic target for thrombosis: Soluble Tissue Factor (sTF). NCI has generated first-in- class antibodies and platform selectively neutralizing pathological coagulation while preserving normal hemostasis. This platform technology can be used to prevent, diagnose and treat pathological thrombosis caused by a variety of clinical conditions-including cancer, sepsis, infectious diseases (e.g., COVID), autoimmune disorders, trauma, heart conditions and inflammatory conditions. It offers a much more sensitive and specific test of thrombosis than the current D-dimer test. It may be applicable to any clinical condition which induces necroptosis, pyroptosis and NETtosis, such as cancer, neurodegenerative disease, ischemia-reperfusion and acute injuries, traumatic injuries, bacterial and viral infections, cardiovascular conditions, and atherosclerosis, inflammatory, autoimmune conditions, and others.
2026-16071, Proposed Collection; 60-Day Comment Request: The Impact of Clinical Research Training and Medical Education at the Clinical Center on Physician Careers in Academia and Clinical Research (Clinical Center)
In compliance with the requirement of the Paperwork Reduction Act of 1995, for opportunity for public comment on proposed data collection projects, the Clinical Center, the National Institutes of Health (NIH) will publish periodic summaries of proposed projects to be submitted to the Office of Management and Budget (OMB) for review and approval.
2026-15565, Proposed Collection; 60-Day Comment Request, Data Use Certification for the NIH Brain Development Cohorts (NBDC) Data Hub, (National Institute on Drug Abuse)
In compliance with the requirement of the Paperwork Reduction Act of 1995 to provide opportunity for public comment on proposed data collection projects, the National Institute on Drug Abuse (NIDA) will publish periodic summaries of proposed projects to be submitted to the Office of Management and Budget (OMB) for review and approval. The purpose of this revision is to update instructions for the Research Data Use Statement and the Progress Report, and to add new instructions for attesting to National Institute of Standards & Technology (NIST) security compliance, and for a Project Close-out at the time of project completion. Burden levels remain unchanged.
2026-14964, Center for Scientific Review; Notice of Closed Meeting
The Center for Scientific Review is holding a closed virtual meeting on August 19, 2026, to review neuroscience career development grant applications. This meeting is private to protect sensitive info like trade secrets and personal details. Researchers applying for these grants should note the date, as funding decisions could impact their projects and careers.
Previous / Next Documents
Previous: 2026-04634, Sunshine Act Meetings
The Legal Services Corporation is holding three virtual committee meetings on March 16, 18, and 19, 2026, open for public viewing on YouTube. These meetings cover updates on leadership councils, legal service delivery, and operations, with some parts possibly closed for sensitive discussions. No new costs or deadlines are introduced, but the public gets a clearer window into how legal aid is managed and improved.
Next: 2026-04636, Certification Notice-258; Notice of Filing of Self-Certification of Coal Capability Under the Powerplant and Industrial Fuel Use Act
South Field Energy LLC has told the Department of Energy that their new power plant can use coal if needed, even though it mainly plans to use natural gas. This is required by law to make sure new power plants can switch fuels if necessary. This notice lets everyone know the plant meets the rules before it starts running, with no extra costs or delays expected.